Evidence map›Paper›PMID 29746167›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2018

A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesion.

Kelley E McQueeney, Joseph M Salamoun, Jennifer G Ahn, Paula Pekic, Isabella K Blanco, Heather L Struckman, Elizabeth R Sharlow, Peter Wipf, John S Lazo

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase.The Journal of pharmacology and experimental therapeutics · 2019
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kelley E McQueeneyFiske Drug Discovery Laboratory, Department of Pharmacology, University of Virginia, Charlottesville, Virginia, USA.
Joseph M SalamounDepartment of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Jennifer G AhnFiske Drug Discovery Laboratory, Department of Pharmacology, University of Virginia, Charlottesville, Virginia, USA.
Paula PekicFiske Drug Discovery Laboratory, Department of Pharmacology, University of Virginia, Charlottesville, Virginia, USA.
Isabella K BlancoFiske Drug Discovery Laboratory, Department of Pharmacology, University of Virginia, Charlottesville, Virginia, USA.
Heather L StruckmanFiske Drug Discovery Laboratory, Department of Pharmacology, University of Virginia, Charlottesville, Virginia, USA.
Elizabeth R SharlowFiske Drug Discovery Laboratory, Department of Pharmacology, University of Virginia, Charlottesville, Virginia, USA.
Peter WipfDepartment of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
John S LazoFiske Drug Discovery Laboratory, Department of Pharmacology, University of Virginia, Charlottesville, Virginia, USA.
University of Virginia · USUniversity of Pittsburgh · US

Funding

Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Thomas P. Loughran · 1987 to 2026
$72.1M
TRAINING IN THE PHARMACOLOGICAL SCIENCEST32GM007055 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LYNCH, KEVIN R. · 1985 to 2022
$7.2M
Operetta CLS High-content Imaging SystemS10OD021723 · OD · UNIVERSITY OF VIRGINIA · PI LAZO, JOHN S. · 2017 to 2017
$516k
PTP4A3 as a Molecular Cancer TargetR21CA191944 · NCI · UNIVERSITY OF VIRGINIA · PI LAZO, JOHN S. · 2014 to 2015
$374k
The Role of PTP4A3 in Colorectal Tumor Formation and ProgressionF31CA196062 · NCI · UNIVERSITY OF VIRGINIA · PI MCQUEENEY, KELLEY · 2016 to 2017
$62k
NCI NIH HHS F31 CA196062NCI NIH HHS P30 CA044579NCI NIH HHS R21 CA191944NIGMS NIH HHS T32 GM007055NIH HHS S10 OD021723
6 · The paper itself

Abstract

Dysregulation of the tightly controlled protein phosphorylation networks that govern cellular behavior causes cancer. The membrane-associated, intracellular protein tyrosine phosphatase PTP4A3 is overexpressed in human colorectal cancer and contributes to cell migration and invasion. To interrogate further the role of PTP4A3 in colorectal cancer cell migration and invasion, we deleted the Ptp4a3 gene from murine colorectal tumor cells. The resulting PTP4A3

Indexed as

AnimalsCell AdhesionCell Line, TumorColonic NeoplasmsExtracellular MatrixImmediate-Early ProteinsMiceMice, KnockoutNeoplasm ProteinsProtein Tyrosine PhosphatasesImmediate-Early ProteinsNeoplasm ProteinsProtein Tyrosine PhosphatasesPtp4a3 protein, mouseEmilinextracellular matrixinhibitormigrationphosphatase

Identifiers

PMID29746167
PMCPMC6133700
OpenAlexW2803080911

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.